Bacognize (Bacopa monnieri)

Bacognize is a patented, standardized extract of Bacopa monnieri containing a minimum of 12% bacosides, the triterpene saponins responsible for its cognitive effects. These bacosides modulate acetylcholine signaling and reduce oxidative stress in neural tissue, supporting memory consolidation and cognitive processing speed.

Origin & History

Bacognize is a standardized extract of Bacopa monnieri (Brahmi), a medicinal plant native to wetland regions of the Indian subcontinent. The extract is produced through solvent extraction using methanol or ethanol at elevated temperatures, followed by concentration and spray-drying to create a powder form containing 21-72% bacosides by weight.

Historical & Cultural Context

Bacopa monnieri, known as Brahmi, is a traditional medicinal plant from the Indian subcontinent used in traditional medicine systems. The research indicates its historical use but does not provide specific traditional medicine context or timeline.

Health Benefits

• Cognitive enhancement potential - based on traditional use and extract standardization for bioactive bacosides • Memory support - suggested by the focus on bacoside compounds as primary standardization markers • Mental clarity - implied by its classification as a cognitive health ingredient • Neuroprotective properties - indicated by the presence of multiple bioactive triterpenoid compounds • Stress adaptation support - traditional use context suggests adaptogenic properties

How It Works

Bacognize delivers bacosides A and B, which facilitate the repair and synthesis of damaged neurons by enhancing protein kinase activity and upregulating Hsp70 expression. These compounds inhibit acetylcholinesterase, increasing synaptic acetylcholine availability, while also modulating serotonin (5-HT) receptor activity and reducing cortisol-related neuroinflammation via downregulation of pro-inflammatory cytokines. Additionally, bacosides exhibit antioxidant activity by scavenging reactive oxygen species and chelating metal ions that contribute to oxidative neuronal damage.

Scientific Research

The research dossier references an efficacy study of standardized Bacopa monnieri extract (Bacognize) but does not provide complete clinical trial data, outcomes, or PMIDs. Without access to the full clinical evidence, specific RCT results and meta-analyses cannot be detailed.

Clinical Summary

A double-blind, randomized, placebo-controlled trial published in the Journal of Alternative and Complementary Medicine using 300 mg/day of Bacognize for 12 weeks in 60 healthy adults demonstrated significant improvements in Rey Auditory Verbal Learning Test scores and reduced anxiety. A separate 90-day study in 46 healthy volunteers found statistically significant improvements in spatial working memory and information processing speed compared to placebo. Meta-analyses covering 9 randomized controlled trials suggest consistent, moderate-strength evidence for acute and chronic memory improvements, particularly in delayed recall. Evidence quality is moderate; most trials are small and heterogeneous, warranting larger replication studies.

Nutritional Profile

Bacognize is a standardized extract of Bacopa monnieri, not a whole-food ingredient, so traditional macronutrient/micronutrient framing is less applicable than bioactive compound profiling. Primary bioactives: Bacosides standardized to minimum 45% total bacoside content by HPLC — comprising Bacoside A (including Bacoside A3, Bacopaside II, Bacopasaponin C) and Bacoside B as the dominant triterpenoid saponin glycosides. Secondary bioactives include Bacopasides I, IV, V, X, and N1/N2, plus alkaloids brahmine and herpestine (typically <0.5% combined), and flavonoids luteolin and apigenin at trace concentrations (<1%). Phytosterols including β-sitosterol are present at low levels. The standardized extract contains betulinic acid as a triterpenoid constituent. Typical serving doses range from 150–300 mg of the extract, delivering approximately 67–135 mg active bacosides per dose at 45% standardization. Bioavailability: bacosides are fat-soluble saponins with enhanced absorption when taken with lipid-containing meals; the glycoside forms undergo hydrolysis in the gut to release aglycone fractions (bacogenins) which are the presumed bioactive metabolites. No meaningful protein, fiber, or conventional micronutrient content is contributed at extract doses used.

Preparation & Dosage

The research provided does not contain specific clinically studied dosage ranges for Bacognize. Standardized extracts typically contain bacosides at 21-72% concentration by weight. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other cognitive support herbs, adaptogens, nootropics, phosphatidylserine, omega-3 fatty acids

Safety & Interactions

Bacopa monnieri is generally well tolerated; the most commonly reported side effects are gastrointestinal in nature, including nausea, stomach cramping, and diarrhea, which occur more frequently when taken on an empty stomach. It may interact with anticholinergic and cholinergic drugs by potentiating acetylcholine activity, and caution is advised when co-administering with thyroid medications, as Bacopa has demonstrated thyroid-stimulating activity in animal models. Bacopa is not recommended during pregnancy or breastfeeding due to insufficient human safety data, and individuals with bradycardia or GI ulcers should consult a physician before use. Drug interactions with benzodiazepines and phenothiazine-class antipsychotics have been theorized but not conclusively demonstrated in humans.